SCHEMBL6581365

SCHEMBL6581365

COc1ccc(-c2nc(-c3cccc(C=O)c3)n(CCF)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 2/20 0.43
NR1H2 P55055 1/20 0.43
AVPR1B P47901 13/20 0.41
TGM2 P21980 1/20 0.41
TGM1 P22735 1/20 0.41
CASP3 P42574 1/20 0.41
TGM3 Q08188 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6584148 0.96 NR1H3 (0.48) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6582921 0.89 NR1H3 (0.43) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6580979 0.89 NR1H2 (0.43) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6580805 0.88 TGM2 (0.51) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6580974 0.88 NR1H3 (0.43) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6581299 0.87 NR1H2 (0.45) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6578716 0.87 NR1H2 (0.51) NR1H3NR1H2AVPR1B
SCHEMBL6580850 0.87 HTT (0.42) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6578727 0.86 NR1H2 (0.43) NR1H3NR1H2AVPR1BTGM2TGM1
SCHEMBL6581102 0.86 NR1H3 (0.57) NR1H3NR1H2AVPR1BCASP3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed